Researchers in Barcelona have recently completed a study in which the possible benefits and risks of a new mesothelioma treatment were examined. The drug, Pemetrexed, sponsored by Eli Lilly and Company, was shown to promote overall disease control rates in individuals that have been diagnosed with p...




This article is courtesy of Mesothelioma Watch

Add to Google